Browse Gene Sets

Gene set name:

 
  (Enter full or partial name)

By first letter:

 

1 2 3 4 5 6 7 8 9 0 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB collections]

  • H (hallmark gene sets, 50 gene sets)
  • C1 (positional gene sets, 278 gene sets)
  • C2 (curated gene sets, 6290 gene sets)
    • CGP (chemical and genetic perturbations, 3368 gene sets)
    • CP (canonical pathways, 2922 gene sets)
  • C3 (regulatory target gene sets, 3731 gene sets)
    • MIR (microRNA targets, 2598 gene sets)
    • TFT (all transcription factor targets, 1133 gene sets)
      • TFT:GTRD (GTRD transcription factor targets, 523 gene sets)
      • TFT:TFT_Legacy (legacy transcription factor targets, 610 gene sets)
  • C4 (computational gene sets, 858 gene sets)
    • CGN (cancer gene neighborhoods, 427 gene sets)
    • CM (cancer modules, 431 gene sets)
  • C5 (ontology gene sets, 14998 gene sets)
    • GO (Gene Ontology, 10185 gene sets)
      • GO:BP (GO biological process, 7481 gene sets)
      • GO:CC (GO cellular component, 996 gene sets)
      • GO:MF (GO molecular function, 1708 gene sets)
    • HPO (Human Phenotye Ontology, 4813 gene sets)
  • C6 (oncogenic signature gene sets, 189 gene sets)
  • C7 (immunologic signature gene sets, 5219 gene sets)
    • IMMUNESIGDB (ImmuneSigDB gene sets, 4872 gene sets)
    • VAX (vaccine response gene sets, 347 gene sets)
  • C8 (cell type signature gene sets, 671 gene sets)

Click on a gene set name to view its gene set page.

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_1DY_DN

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_1DY_UP

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_3DY_DN

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_3DY_UP

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_6HR_DN

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_6HR_UP

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_7DY_DN

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_7DY_UP

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_R
ESPONDERS_3DY_7D_DN

ANDERSON_BLOOD_CN54GP140_ADJUVANTED
_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RE
SPONDERS_6HY_1DY_UP

BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCA
SIAN_MALE_AGE_18_40YO_HIGH_RESPONDE
RS_1DY_3DY_POSITIVE_PREDICTIVE_OF_T
ITER

BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCA
SIAN_MALE_AGE_18_40YO_HIGH_RESPONDE
RS_1DY_TOP_FUNCTIONAL_NETWORK_POSIT
IVE

BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCA
SIAN_MALE_AGE_18_40YO_LOW_RESPONDER
S_1DY_POSITIVE_PREDICTIVE_OF_TITER

CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_D
N

CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_U
P

CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_
DN

CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_
UP

CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_D
N

CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_U
P

CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRE
LATED_WITH_H3N2_VN_TITER_7DY_POSITI
VE

CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_D
N

CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_U
P

CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_
DN

CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_
UP

CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_D
N

CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_U
P

CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRE
LATED_WITH_H3N1_HI_TITER_1DY_POSITI
VE

COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE
_03_17YO_7DY_UP

COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_1
7YO_7DY_DN

DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_S
UBQ_7_OR_14DY_DN

DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_S
UBQ_7_OR_14DY_UP

ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_8
3_AGE_23_48YO_VACCINATED_VS_CONTROL
_14DY_UP

ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO
_VACCINATED_VS_CONTROL_2DY_UP

ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE
_23_48YO_VACCINATED_VS_CONTROL_14DY
_DN

ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE
_23_48YO_VACCINATED_VS_CONTROL_2DY_
DN

ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE
_23_48YO_VACCINATED_VS_CONTROL_7DY_
DN

ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE
_23_48YO_VACCINATED_VS_CONTROL_7DY_
UP

ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_
NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR
_DEG_CANONICAL_PATHWAY_MEMBERS_UP

ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_
NON_RESPONDERS_PREVIOUSLY_IMMUNIZED
_24HR_DEG_CANONICAL_PATHWAY_MEMBERS
_DN

ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_
NON_RESPONDERS_PREVIOUSLY_IMMUNIZED
_24HR_DEG_CANONICAL_PATHWAY_MEMBERS
_UP

ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_
RESPONDERS_PREVIOUSLY_IMMUNIZED_24H
R_DEG_CANONICAL_PATHWAY_MEMBERS_UP

FISCHER_BLOOD_PLASMA_RVSV_EBOV_AGE_
18_55YO_HIGH_DOSE_3DY_DN

FLETCHER_PBMC_BCG_10W_INFANT_BCG_ST
IMULATED_VS_UNSTIMULATED_10W_DN

FLETCHER_PBMC_BCG_10W_INFANT_BCG_ST
IMULATED_VS_UNSTIMULATED_10W_UP

FLETCHER_PBMC_BCG_10W_INFANT_PPD_ST
IMULATED_VS_UNSTIMULATED_10W_DN

FLETCHER_PBMC_BCG_10W_INFANT_PPD_ST
IMULATED_VS_UNSTIMULATED_10W_UP

FOURATI_BLOOD_TWINRIX_AGE_25_83YO_R
ESPONDERS_VS_POOR_RESPONDERS_0DY_DN

FOURATI_BLOOD_TWINRIX_AGE_25_83YO_R
ESPONDERS_VS_POOR_RESPONDERS_0DY_UP

FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_R
ESPONDERS_VS_POOR_RESPONDERS_TRAINI
NG_SET_0DY_NETWORK_INFERENCE_UP

FOURATI_BLOOD_TWINRIX_AGE_65_81YO_R
ESPONDERS_VS_POOR_RESPONDERS_TRAINI
NG_SET_0DY_NETWORK_INFERENCE_DN

FOURATI_BLOOD_TWINRIX_AGE_65_83YO_P
OOR_RESPONDERS_VS_RESPONDERS_0DY_NE
TWORK_INFERENCE_UP

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_0DY_NEGATIVE

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_0DY_POSITIVE

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_14DY_NEGATIVE

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_14DY_POSITIVE

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_1DY_NEGATIVE

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_1DY_POSITIVE

FRANCO_BLOOD_SANOFI_PASTEUR_SA_INAC
TIVATED_INFLUENZA_VACCINE_CORRELATE
D_WITH_ANTIBODY_RESPONSE_AGE_18_40Y
O_3DY_POSITIVE

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_18HR_DN

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_18HR_TO_336HR_SUSTAIN
ED_UP

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_18HR_TO_48HR_EARLY_DN

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_18HR_TO_48HR_EARLY_UP

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_18HR_UP

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_192HR_DN

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_192HR_UP

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_336HR_DN

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_336HR_UP

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_48HR_DN

FULLER_PBMC_F_TULARENSIS_VACCINE_LV
S_AGE_22_54YO_48HR_UP

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_12MO_CORRELATED_WITH_ANT
IBODY_RESPONSE_NEGATIVE

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_12MO_CORRELATED_WITH_ANT
IBODY_RESPONSE_POSITIVE

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_2MO_DN

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_2MO_UP

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_7MO_CORRELATED_WITH_ANTI
BODY_RESPONSE_NEGATIVE

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_7MO_CORRELATED_WITH_ANTI
BODY_RESPONSE_POSITIVE

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_STIMULATED_VS_UNSTIMULAT
ED_0DY_VACCINATION_INDEPENDENT_DN

GARCIA_PINERES_PBMC_HPV_16_L1_VLP_A
GE_18_25YO_STIMULATED_VS_UNSTIMULAT
ED_0DY_VACCINATION_INDEPENDENT_UP

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_10DY_DN

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_10DY_UP

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_14DY_DN

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_14DY_UP

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_28DY_DN

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_28DY_UP

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_3DY_DN

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_3DY_UP

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_60DY_DN

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_60DY_UP

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_7DY_DN

GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOW
N_AGE_7DY_UP

GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE
_21_51YO_3DY_UP

GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_2
1_51YO_30DY_UP

GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_2
1_51YO_3DY_UP

HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40Y
O_STIMULATED_VS_UNSTIMULATED_9_TO_3
4MO_UP

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_0DY_NEGATIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_0DY_POSITIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_28DY_LATE_GENE_EXPR_INDIVID_GE
NE_MODELS_PRED_PEAK_B_CELL_ELISPOT_
RESP_NEGATIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_28DY_LATE_GENE_EXPR_INDIVID_GE
NE_MODELS_PRED_PEAK_B_CELL_ELISPOT_
RESP_POSITIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_
SIG_DIAB_OF_THE_YNG_NEGATIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_
SIG_DIAB_OF_THE_YNG_POSITIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_28DY_POSITIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_3DY_NEGATIVE

HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74
YO_CORR_WITH_28D_MEM_B_CELL_RESPONS
E_AT_3DY_POSITIVE

HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_2
2YO_VACCINATED_VS_UNVACCINATED_7YR_
DN

HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_2
2YO_VACCINATED_VS_UNVACCINATED_7YR_
UP

HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_2
2YO_VACCINATED_VS_UNVACCINATED_HIGH
_ANTIBODY_RESPONDERS_TO_TREATMENT_7
YR_DN

HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_2
2YO_VACCINATED_VS_UNVACCINATED_LOW_
ANTIBODY_RESPONDERS_TO_TREATMENT_7Y
R_DN

HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_2
2YO_VACCINATED_VS_UNVACCINATED_LOW_
ANTIBODY_RESPONDERS_TO_TREATMENT_7Y
R_UP

HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_1
6YO_STIMULATED_VS_UNSTIMULATED_3_TO
_7YR_POST_TOP_DEG_UP

HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_C
ORRELATED_WITH_MEMORY_B_CELL_RESPON
SE_28DY_NEGATIVE

HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_C
ORRELATED_WITH_MEMORY_B_CELL_RESPON
SE_3DY_NEGATIVE

HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_C
ORRELATED_WITH_MEMORY_B_CELL_RESPON
SE_3DY_POSITIVE

HIPC_SIGNATURES_PROJECT_PBMC_TRIVAL
ENT_INFLUENZA_VACCINE_HIGH_RESPONDE
RS_VS_LOW_RESPONDERS_YOUNGER_ADULTS
_21_35_HIGH_RESPONDERS_0D_DOWN

HIPC_SIGNATURES_PROJECT_PBMC_TRIVAL
ENT_INFLUENZA_VACCINE_HIGH_RESPONDE
RS_VS_LOW_RESPONDERS_YOUNGER_ADULTS
_21_35_HIGH_RESPONDERS_0D_UP

HOEK_B_CELL_2011_2012_TIV_ADULT_1DY
_UP

HOEK_B_CELL_2011_2012_TIV_ADULT_3DY
_DN

HOEK_B_CELL_2011_2012_TIV_ADULT_3DY
_UP

HOEK_B_CELL_2011_2012_TIV_ADULT_7DY
_DN

HOEK_B_CELL_2011_2012_TIV_ADULT_7DY
_UP

HOEK_MONOCYTE_2011_2012_TIV_ADULT_1
DY_DN

HOEK_MONOCYTE_2011_2012_TIV_ADULT_1
DY_UP

HOEK_MONOCYTE_2011_2012_TIV_ADULT_3
DY_DN

HOEK_MONOCYTE_2011_2012_TIV_ADULT_3
DY_UP

HOEK_MONOCYTE_2011_2012_TIV_ADULT_7
DY_DN

HOEK_MONOCYTE_2011_2012_TIV_ADULT_7
DY_UP

HOEK_MYELOID_DENDRITIC_CELL_2011_20
12_TIV_ADULT_1DY_DN

HOEK_MYELOID_DENDRITIC_CELL_2011_20
12_TIV_ADULT_1DY_UP

HOEK_MYELOID_DENDRITIC_CELL_2011_20
12_TIV_ADULT_3DY_DN

HOEK_MYELOID_DENDRITIC_CELL_2011_20
12_TIV_ADULT_3DY_UP

HOEK_MYELOID_DENDRITIC_CELL_2011_20
12_TIV_ADULT_7DY_DN

HOEK_MYELOID_DENDRITIC_CELL_2011_20
12_TIV_ADULT_7DY_UP

HOEK_NEUTROPHIL_2011_2012_TIV_ADULT
_1DY_DN

HOEK_NEUTROPHIL_2011_2012_TIV_ADULT
_1DY_UP

HOEK_NEUTROPHIL_2011_2012_TIV_ADULT
_3DY_DN

HOEK_NEUTROPHIL_2011_2012_TIV_ADULT
_3DY_UP

HOEK_NEUTROPHIL_2011_2012_TIV_ADULT
_7DY_DN

HOEK_NEUTROPHIL_2011_2012_TIV_ADULT
_7DY_UP

HOEK_NK_CELL_2011_2012_TIV_1D_VS_0D
Y_ADULT_1D_DN

HOEK_NK_CELL_2011_2012_TIV_3D_VS_0D
Y_ADULT_3D_DN

HOEK_NK_CELL_2011_2012_TIV_7D_VS_0D
Y_ADULT_7D_DN

HOEK_NK_CELL_2011_2012_TIV_ADULT_1D
Y_UP

HOEK_NK_CELL_2011_2012_TIV_ADULT_3D
Y_UP

HOEK_NK_CELL_2011_2012_TIV_ADULT_7D
Y_UP

HOEK_PBMC_INACTIVATED_INFLUENZA_ADU
LT_1DY_DN

HOEK_PBMC_INACTIVATED_INFLUENZA_ADU
LT_1DY_UP

HOEK_PBMC_INACTIVATED_INFLUENZA_ADU
LT_3DY_DN

HOEK_PBMC_INACTIVATED_INFLUENZA_ADU
LT_3DY_UP

HOEK_PBMC_INACTIVATED_INFLUENZA_ADU
LT_7DY_DN

HOEK_PBMC_INACTIVATED_INFLUENZA_ADU
LT_7DY_UP

HOEK_T_CELL_2011_2012_TIV_ADULT_1DY
_DN

HOEK_T_CELL_2011_2012_TIV_ADULT_1DY
_UP

HOEK_T_CELL_2011_2012_TIV_ADULT_3DY
_DN

HOEK_T_CELL_2011_2012_TIV_ADULT_3DY
_UP

HOEK_T_CELL_2011_2012_TIV_ADULT_7DY
_UP

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_56D
_TOP_100_DEG_AFTER_IN_VITRO_RE_STIM
ULATION_DN

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_56D
_TOP_100_DEG_AFTER_IN_VITRO_RE_STIM
ULATION_UP

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY
_DN

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY
_UP

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_
56D_TOP_100_DEG_AFTER_IN_VITRO_RE_S
TIMULATION_DN

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_
56D_TOP_100_DEG_AFTER_IN_VITRO_RE_S
TIMULATION_UP

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_
7DY_TOP_100_DEG_EX_VIVO_DN

HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY
_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_
7DY_TOP_100_DEG_EX_VIVO_UP

HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B
_AGE_18_40YO_CORRELATED_WITH_WHOLE_
BLOOD_BACTERICIDAL_ACTIVITY_NEGATIV
E

HOWARD_B_CELL_INACT_MONOV_INFLUENZA
_A_INDONESIA_05_2005_H5N1_AGE_18_49
YO_1DY_UP

HOWARD_DENDRITIC_CELL_INACT_MONOV_I
NFLUENZA_A_INDONESIA_05_2005_H5N1_A
GE_18_49YO_1DY_DN

HOWARD_DENDRITIC_CELL_INACT_MONOV_I
NFLUENZA_A_INDONESIA_05_2005_H5N1_A
GE_18_49YO_1DY_UP

HOWARD_DENDRITIC_CELL_INACT_MONOV_I
NFLUENZA_A_INDONESIA_05_2005_H5N1_A
GE_18_49YO_3DY_UP

HOWARD_MONOCYTE_INACT_MONOV_INFLUEN
ZA_A_INDONESIA_05_2005_H5N1_AGE_18_
49YO_1DY_DN

HOWARD_MONOCYTE_INACT_MONOV_INFLUEN
ZA_A_INDONESIA_05_2005_H5N1_AGE_18_
49YO_1DY_UP

HOWARD_NEUTROPHIL_INACT_MONOV_INFLU
ENZA_A_INDONESIA_05_2005_H5N1_AGE_1
8_49YO_1DY_DN

HOWARD_NEUTROPHIL_INACT_MONOV_INFLU
ENZA_A_INDONESIA_05_2005_H5N1_AGE_1
8_49YO_1DY_UP

HOWARD_NEUTROPHIL_INACT_MONOV_INFLU
ENZA_A_INDONESIA_05_2005_H5N1_AGE_1
8_49YO_3DY_DN

HOWARD_NEUTROPHIL_INACT_MONOV_INFLU
ENZA_A_INDONESIA_05_2005_H5N1_AGE_1
8_49YO_3DY_UP

HOWARD_NK_CELL_INACT_MONOV_INFLUENZ
A_A_INDONESIA_05_2005_H5N1_AGE_18_4
9YO_1DY_UP

HOWARD_NK_CELL_INACT_MONOV_INFLUENZ
A_A_INDONESIA_05_2005_H5N1_AGE_18_4
9YO_28DY_DN

HOWARD_NK_CELL_INACT_MONOV_INFLUENZ
A_A_INDONESIA_05_2005_H5N1_AGE_18_4
9YO_3DY_UP

HOWARD_PBMC_INACT_MONOV_INFLUENZA_A
_INDONESIA_05_2005_H5N1_AGE_19_39YO
_AS03_ADJUVANT_VS_BUFFER_1DY_DN

HOWARD_PBMC_INACT_MONOV_INFLUENZA_A
_INDONESIA_05_2005_H5N1_AGE_19_39YO
_AS03_ADJUVANT_VS_BUFFER_1DY_UP

HOWARD_T_CELL_INACT_MONOV_INFLUENZA
_A_INDONESIA_05_2005_H5N1_AGE_18_49
YO_1DY_UP

KANNAN_BLOOD_2012_2013_TIV_AGE_65PL
S_REVACCINATED_IN_6_9_MO_VS_REVACCI
NATED_IN_12_13_MO_UP

KANNAN_BLOOD_2012_2013_TIV_AGE_65PL
S_REVACCINATED_IN_6_9_MO_VS_REVACCI
NATED_IN_12_13_MOS_DN

KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_
AGE_UNKNOWN_CORRELATED_WITH_PROTECT
ION_56DY_NEGATIVE

KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_
AGE_UNKNOWN_CORRELATED_WITH_PROTECT
ION_56DY_POSITIVE

KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_
UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR
_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOV
IRUS_35_1DY_UP

KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STI
MULATED_VS_UNSTIMULATED_1_TO_48MO_T
OP_DEG_DN

KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STI
MULATED_VS_UNSTIMULATED_1_TO_48MO_T
OP_DEG_UP

LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP
LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_D
T_ANTIBODY_CORRELATION_PROFILE_3DY_
DN

LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_D
T_ANTIBODY_CORRELATION_PROFILE_3DY_
UP

LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_P
OLYSACCHARIDE_ANTIBODY_CORRELATION_
PROFILE_3DY_DN

LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_P
OLYSACCHARIDE_ANTIBODY_CORRELATION_
PROFILE_3DY_UP

LI_PBMC_MENACTRA_AGE_18_45YO_CORREL
ATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGA
TIVE

LI_PBMC_MENACTRA_AGE_18_45YO_CORREL
ATED_WITH_ANTI_DT_ANTIBODY_3DY_POSI
TIVE

LI_PBMC_MENACTRA_AGE_18_45YO_CORREL
ATED_WITH_ANTI_POLYSACCHARIDE_ANTIB
ODY_3DY_NEGATIVE

LI_PBMC_MENACTRA_AGE_18_45YO_CORREL
ATED_WITH_ANTI_POLYSACCHARIDE_ANTIB
ODY_3DY_POSITIVE

LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18
_45YO_3DY_DN

LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18
_45YO_3DY_UP

LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18
_45YO_CORRELATED_WITH_ANTIBODY_RESP
ONSE_3DY_NEGATIVE

LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18
_45YO_CORRELATED_WITH_ANTIBODY_RESP
ONSE_3DY_POSITIVE

LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_7
9YO_1DY_UP

LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_7
9YO_3DY_UP

MATSUMIYA_BLOOD_MODIFIED_VACCINIA_A
NKARA_VACCINE_AGE_4_6MO_VACCINATED_
VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN

MATSUMIYA_BLOOD_MODIFIED_VACCINIA_A
NKARA_VACCINE_AGE_4_6MO_VACCINATED_
VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_18_55YO_2DY_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_18_55YO_HIGH_RESPO
NDERS_VS_LOW_RESPONDERS_0DY_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_18_55YO_LOW_VS_HIG
H_RESPONDERS_2DY_GO_T_CELL_ACTIV_AN
D_CO_STIM_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_18_55YO_VACCINATED
_VS_CONTROL_TREATED_IN_VITRO_WITH_M
VA85A_6HR_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_18_55YO_VACCINATED
_VS_CONTROL_TREATED_IN_VITRO_WITH_W
ILD_TYPE_MVA_6HR_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_4_6MO_BCG_PRIMED_2
8DY_UP

MATSUMIYA_PBMC_MODIFIED_VACCINIA_AN
KARA_VACCINE_AGE_4_6MO_VACCINATED_V
S_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP

NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_
18_50YO_7DY_DN

NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_
18_50YO_7DY_UP

NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7
DY_DN

NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7
DY_UP

NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AG
E_18_50YO_7DY_DN

NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AG
E_18_50YO_7DY_UP

NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO
_7DY_DN

NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO
_7DY_UP

NAKAYA_MYELOID_DENDRITIC_CELL_FLUAR
IX_FLUVIRIN_AGE_18_50YO_7DY_DN

NAKAYA_MYELOID_DENDRITIC_CELL_FLUAR
IX_FLUVIRIN_AGE_18_50YO_7DY_UP

NAKAYA_MYELOID_DENDRITIC_CELL_FLUMI
ST_AGE_18_50YO_7DY_DN

NAKAYA_MYELOID_DENDRITIC_CELL_FLUMI
ST_AGE_18_50YO_7DY_UP

NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_1
4_27YO_CORRELATED_WITH_HAI_RESPONSE
_MF59_ADJUVANTED_AND_NON_1DY_GENES_
IN_BTM_M75_POSITIVE

NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_
1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJU
VANTED_1DY_ATIV_UP

NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_
1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJU
VANTED_1DY_GENES_IN_BTM_M40_AND_M53
_DN

NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_
1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJU
VANTED_1DY_GENES_IN_BTM_M40_AND_M53
_UP

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_3DY_DN

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_3DY_UP

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_7DY_DN

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_7DY_UP

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_CORRELATED_WITH_HAI_28DY_RESP
ONSE_AT_3DY_NEGATIVE

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_CORRELATED_WITH_HAI_28DY_RESP
ONSE_AT_3DY_POSITIVE

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_CORRELATED_WITH_HAI_28DY_RESP
ONSE_AT_7DY_NEGATIVE

NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18
_50YO_CORRELATED_WITH_HAI_28DY_RESP
ONSE_AT_7DY_POSITIVE

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY
_DN

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY
_IFN_SUBSET_UP

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY
_UP

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY
_DN

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY
_IFN_SUBSET_DN

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY
_IFN_SUBSET_UP

NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY
_UP

NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO
_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP

NAKAYA_PLASMACYTOID_DENDRITIC_CELL_
FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN

NAKAYA_PLASMACYTOID_DENDRITIC_CELL_
FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP

NAKAYA_PLASMACYTOID_DENDRITIC_CELL_
FLUMIST_AGE_18_50YO_7DY_DN

NAKAYA_PLASMACYTOID_DENDRITIC_CELL_
FLUMIST_AGE_18_50YO_7DY_UP

OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_
70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_A
FTER_FIRST_DOSE_DN

OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_
70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_A
FTER_FIRST_DOSE_UP

OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_H
IGH_DOSE_SUBJECTS_24HR_DN

OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_H
IGH_DOSE_SUBJECTS_24HR_UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_0DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_0DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_3DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74
YO_COMMON_WITH_BOTH_HAI_AND_VNA_28D
Y_VS_3DY_USED_IN_HAI_AND_VNA_RESPON
SE_MODELS_UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_0DY_
DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_0DY_
UP

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_28DY
_DN

OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64
YO_RESPONDERS_VS_NONRESPONDERS_28DY
_UP

PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3
DY_4DY_DN

PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6
DY_7DY_UP

PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_
93YO_VZV_CHALLENGE_3DY_DN

PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_
93YO_VZV_CHALLENGE_3DY_UP

PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_
93YO_VZV_CHALLENGE_6HR_DN

PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_
93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_U
P

PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_
93YO_VZV_CHALLENGE_6HR_UP

PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_
93YO_VZV_CHALLENGED_POST_VACCINATIO
N_VS_UNCHALLENGED_72HR_TOP_30_DEG_U
P

QI_CD4_POSITIVE_ALPHA_BETA_MEMORY_T
_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CE
LL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN

QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75Y
O_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_
TO_9DY_DN

QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75Y
O_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_
TO_9DY_UP

QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_28D_PEAK_T_CELL_RESPONSE_
14DY_NEGATIVE

QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_CONTRACTION_OF_VZV_SPECIF
IC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSIT
IVE

QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_CONTRACTION_OF_VZV_SPECIF
IC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGAT
IVE

QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_EXPANSION_OF_VZV_SPECIFIC
_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE

QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_EXPANSION_OF_VZV_SPECIFIC
_T_CELLS_TO_PEAK_AT_1DY_POSITIVE

QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_T_CELL_RESPONSES_1D_INFOR
MATIVE_OF_LONG_TERM_RESPONSES_NEGAT
IVE

QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORREL
ATED_WITH_T_CELL_RESPONSES_EXPANSIO
N_AND_CONTRACTION_1D_NOT_INFORMATIV
E_OF_LONG_TERM_RESPONSES_POSITIVE

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_0_TO_35DY_JOINTLY_UP

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_0DY_UP

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_28DY_DN

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_28DY_UP

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_35DY_UP

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_3DY_UP

QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIG
EN_AGE_UNDER50_NON_RESPONDERS_VS_RE
SPONDERS_7DY_UP

QUEREC_MODEL_PBMC_YF_17D_VACCINE_AG
E_18_45_7DY_PREDICTIVE

QUEREC_MODEL_PBMC_YF_17D_VACCINE_AG
E_18_45YO_3DY_PREDICTIVE

QUEREC_PBMC_YF_17D_VACCINE_AGE_18_4
5YO_3DY_UP

QUEREC_PBMC_YF_17D_VACCINE_AGE_18_4
5YO_7DY_UP

RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55Y
O_1DY_UP

RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO
_STIMULATED_VS_UNSTIMULATED_0W_14W_
METALLOTHIONEIN_SUBSET_UP

RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO
_STIMULATED_VS_UNSTIMULATED_14W_INT
ERFERON_SUBSET_UP

RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO
_STIMULATED_VS_UNSTIMULATED_14W_SIG
NIFICANT_VARIATION_UP

RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO
_STIMULATED_VS_UNSTIMULATED_14W_TOP
_FUNCTIONAL_NETWORK_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_2_TO_4DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_2_TO_4DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_50_TO_60DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_50_TO_60DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_5_TO_7DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_32Y
O_5_TO_7DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_40Y
O_5_TO_7DY_DN

SCHERER_PBMC_APSV_WETVAX_AGE_18_40Y
O_5_TO_7DY_UP

SCHERER_PBMC_APSV_WETVAX_AGE_18_40Y
O_JOINT_TO_VACCINIA_AND_YELLOW_FEVE
R_UP

SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_T
O_7DY_DN

SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_T
O_7DY_UP

SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANY
D_DN

SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANY
D_UP

SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOI
NT_TO_VACCINIA_AND_YELLOW_FEVER_UP

SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_
AGE_18_40YO_JOINT_TO_VACCINIA_AND_Y
ELLOW_FEVER_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
1DY_UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
7DY_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
CORRELATED_WITH_AGE_1DY_POSITIVE

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_
ADVERSE_EVENTS_SCORE_1DY_CORRELATED
_WITH_TRANSITIONAL_B_CELLS_UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_
ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_
UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SU
BJECTS_0DY_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_
1DY_UP

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1D
Y_DN

SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_
RESPONDERS_VS_NONRESPONDERS_7DY_UP

SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64Y
O_1DY_UP

SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64Y
O_7DY_DN

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_NONRESPONDER_28DY_DN

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_NONRESPONDER_28DY_UP

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_NONRESPONDER_7DY_DN

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_NONRESPONDER_7DY_UP

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_RESPONDERS_28DY_DN

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_RESPONDERS_28DY_UP

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_RESPONDERS_7DY_DN

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_RESPONDERS_7DY_UP

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_21_30YO_VS_70PLS_0DY_UP

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_70PLS_NONRESPONDER_2DY_DN

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_70PLS_NONRESPONDER_2DY_UP

THAKAR_PBMC_INACTIVATED_INFLUENZA_A
GE_70PLS_VS_21_30YO_0DY_UP

TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT
_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_
CD20_NEG_PLASMABLASTS_AND_CD38PLUS_
OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POS
ITIVE

VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_
INFANT_STIMULATED_VS_UNSTIMULATED_8
MO_UP

VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_
INFANT_STIMULATED_VS_UNSTIMULATED_9
MO_DN

VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_
INFANT_STIMULATED_VS_UNSTIMULATED_9
MO_UP

VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMA
LES_VS_MALES_0DY_TO_28D_UP

WEINBERGER_BLOOD_TWINRIX_AGE_20_40_
AND_60_84YO_CORRELATED_WITH_ANTI_HB
S_CONC_PRIMARY_VACC_1DY_SIGNIFICANT

WEINBERGER_BLOOD_TWINRIX_AGE_20_40_
AND_60_84YO_CORRELATED_WITH_HIGH_AN
TI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC
_1DY_POSITIVE

WEINBERGER_BLOOD_TWINRIX_AGE_20_40_
AND_60_84YO_CORRELATED_WITH_HIGH_AN
TI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_
VACC_1DY_POSITIVE

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_1DY_ADDNL_EXON_LVL_UP

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_1DY_DN

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_1DY_UP

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_3DY_DN

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_3DY_UP

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_AD5_NAB_TITERS_GT_200_VS
_LTE_200_1DY_DN

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_AD5_NAB_TITERS_GTE_200_V
S_LTE_200_1DY_UP

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_CORRELATED_WITH_CD8_T_CE
LL_RESPONSE_3DY_NEGATIVE

ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_A
GE_20_50YO_CORRELATED_WITH_CD8_T_CE
LL_RESPONSE_3DY_POSITIVE